# Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.

> **NCT00408473** · PHASE4 · TERMINATED · sponsor: **MEDA Pharma GmbH & Co. KG** · enrollment: 256 (—)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Flecainide

## Key facts

- **NCT ID:** NCT00408473
- **Lead sponsor:** MEDA Pharma GmbH & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 256 (—)
- **Last updated:** 2022-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00408473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00408473, "Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00408473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*